(Q39681246)

English

Detection of prostate cancer in men with prostate-specific antigen levels of 2.0 to 4.0 ng/mL equivalent to that in men with 4.1 to 10.0 ng/mL in a Japanese population

scientific article published on April 2004

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Detection of prostate cancer in men with prostate-specific antigen levels of 2.0 to 4.0 ng/mL equivalent to that in men with 4.1 to 10.0 ng/mL in a Japanese population (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Takashi Kobayashi

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Koji Nishizawa

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Keiji Ogura

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Kenji Mitsumori

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Yoshihiro Ide

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

language of work or name

0 references

publication date

1 April 2004

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

63

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

727-731

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Screening with low PSA cutoff values results in low rates of positive surgical margins in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.025

7 January 2021

Effectiveness of mass screening for the prognosis of prostate cancer patients in Japanese communities

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.025

7 January 2021

Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.025

7 January 2021

Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.025

7 January 2021

Early detection of prostate cancer. Results of a prostate specific antigen-based detection program in Japan

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.025

7 January 2021

Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.025

7 January 2021

The epidemiology of prostatic cancer. Geographical distribution and time-trends

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.025

7 January 2021

Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.025

7 January 2021

Dynamic endorectal magnetic resonance imaging for local staging and detection of neurovascular bundle involvement of prostate cancer: correlation with histopathologic results

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.025

7 January 2021

Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.025

7 January 2021

Japanese men have smaller prostate volumes but comparable urinary flow rates relative to American men: results of community based studies in 2 countries

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.025

7 January 2021

Cancer diagnosis with prostate specific antigen greater than 10 ng./ml. and negative peripheral zone prostate biopsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.025

7 January 2021

The influence of prostate size on cancer detection

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.025

7 January 2021

Correlation between preoperative predictors and pathologic features in radical prostatectomy specimens in PSA-based screening

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.025

7 January 2021

Prediction of prostate cancer volume using prostate-specific antigen levels, transrectal ultrasound, and systematic sextant biopsies

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.025

7 January 2021

The diagnostic accuracy of the age-adjusted and prostate volume-adjusted biopsy method in males with prostate specific antigen levels of 4.1-10.0 ng/mL

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.025

7 January 2021

The Pathological Features and Prognosis of Prostate Cancer Detectable With Current Diagnostic Tests

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.11.025

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.UROLOGY.2003.11.025

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39681246&oldid=1855532784"